Inflammatory respiratory digestive and endocrine disorders, clinical performance is complex and often involves multi-system congestion. Early identification and normalisation of the diagnosis are essential for improving the prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging checks, laboratory checks and pathological checks.
The platform can help to combine a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of PF-ILD-associated respiratory freeze-in-pulmonary activation needs to be individualized, typically including multidimensional management, including drug therapy, rehabilitation interventions, regular follow-up, and more. In recent years, with the development of targeted therapy, immune regulation therapy, and precision medicine, many previously difficult-to-treat infectious respiratory digestive and endocrine diseases have been significantly improved.
Therapeutic efficacy and adverse reactions need to be closely monitored throughout the treatment process, adjusting the regimen in a timely manner according to changing conditions. Multidisciplinary collaboration (MDT) is particularly important for integrated management of PF-ILD-associated respiratory freeze-in-pulmonary activation. The platform serves the China International Medical Service System, which combines domestic and foreign authoritative teams of experts in the field of infectious respiratory digestive and endocrine secretion to provide the following services to patients: 1.
Remote pre-diagnosis: Pre-examination of medical records, clear diagnostic directions and medical advice by the team of experts; 2. Interviews in China: Arrangements with authoritative experts for face-to-face diagnosis, development of personalized treatment programs; 3. Full-service: One-stop services: Medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: Establishment of a chronic disease management file, continuous monitoring of changes in disease and treatment effects. Support for remote pre-diagnosis, visiting interviews, full translation and escort.